Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Chinese Journal of Cancer Biotherapy
>
2018
>
25
>
6
Volume:
25
Issue:
6
1. Development status and prospects of cell therapy industry in China
Page:549—554
2. Effect and mechanism of lncRNA UCA1 target regulating miR-185-5p on non-small cell lung cancerA549 cell
Page:555—561
3. Effect of TTTY10 regulating miR-490-3p on migration and invasion of cervical cancer cell via HMGB1 signaling pathway
Page:562—567
4. Effect of shRNA interfering BAMBI on malignant biological behaviors of human colon cancer SW480 cell
Page:568—573
5. Effect of co-culture with amniotic epithelial cells on biological characteristics of amniotic mesenchymal stem cells
Page:574—581
6. In vitro anti-tumor effect of mGM-CSF-GnRH3 and mGM-CSF-GRP6 recombinant fusion protein and theirbioinformatics prediction
Page:582—589
7. Ginsenoside Rg3 regulates CaM gene expression through PI3K/AKT signal system to promote apoptosis of gastric cancer BGC-823 cell
Page:590—594
8. Resistance of CD133+ cells in HepG2 cell line to doxorubicin and its mechanism
Page:595—600
9. Licorice enhances radio-sensitivity of nasopharyngeal carcinoma CNE-2 cells by affecting autophagy
Page:601—606
10. Establishment of cisplatin-resistant breast cancer cell line and role of FANCF gene in cisplatin resistance
Page:607—612
11. Expression of miR-133a-3p in gastric cancer tissues and plasma and its effect on proliferation of gastric cancercells
Page:613—619
12. Expression of RUNX1 isoformsand its clinical significance in acute leukemia
Page:620—628
13. Expression and clinical significance of Flotillin-2 in gastric cancer tissues
Page:629—633
14. Research progress of PD-1/PD-L1 inhibitors in the treatment of acute myeloid leukemia
Page:634—639
15. Research progress of bone destruction related signaling pathways in bone metastases from lung cancer
Page:640—644
16. Research progress of the role and regulation mechanism of IDH1 in tumorigenesis
Page:645—651
17. Research progress on the role ofARL2 in the development of tumo
Page:652—655
18. MELK:a new moleculartargeted therapeutic target formalignant tumors
Page:656—659